# Clinical Pre-screening Protocol for Ovarian Cancer

> **NCT03877796** · — · RECRUITING · sponsor: **Allarity Therapeutics** · enrollment: 60 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DEVICE:** Drug Response Predictor® (DRP)

## Key facts

- **NCT ID:** NCT03877796
- **Lead sponsor:** Allarity Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-04-11
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03877796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03877796, "Clinical Pre-screening Protocol for Ovarian Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03877796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*